NO300735B1 - Tiazolidindionderivater samt farmasöytiske preparater inneholdende dem - Google Patents
Tiazolidindionderivater samt farmasöytiske preparater inneholdende dem Download PDFInfo
- Publication number
- NO300735B1 NO300735B1 NO934833A NO934833A NO300735B1 NO 300735 B1 NO300735 B1 NO 300735B1 NO 934833 A NO934833 A NO 934833A NO 934833 A NO934833 A NO 934833A NO 300735 B1 NO300735 B1 NO 300735B1
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- phenyl
- compound
- oxazolyl
- thiazolidinedione
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34856892 | 1992-12-28 | ||
| JP18099693 | 1993-07-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO934833D0 NO934833D0 (no) | 1993-12-27 |
| NO934833L NO934833L (no) | 1994-06-29 |
| NO300735B1 true NO300735B1 (no) | 1997-07-14 |
Family
ID=26500340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO934833A NO300735B1 (no) | 1992-12-28 | 1993-12-27 | Tiazolidindionderivater samt farmasöytiske preparater inneholdende dem |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5489602A (enExample) |
| EP (1) | EP0605228B1 (enExample) |
| JP (1) | JP3741452B2 (enExample) |
| KR (1) | KR100292363B1 (enExample) |
| CN (1) | CN1056372C (enExample) |
| AT (1) | ATE190052T1 (enExample) |
| AU (1) | AU666414B2 (enExample) |
| CA (1) | CA2112283A1 (enExample) |
| CZ (1) | CZ288363B6 (enExample) |
| DE (1) | DE69327944T2 (enExample) |
| DK (1) | DK0605228T3 (enExample) |
| ES (1) | ES2142852T3 (enExample) |
| FI (1) | FI935887L (enExample) |
| GR (1) | GR3033487T3 (enExample) |
| HU (1) | HUT69383A (enExample) |
| MX (1) | MX9400190A (enExample) |
| MY (1) | MY110142A (enExample) |
| NO (1) | NO300735B1 (enExample) |
| PT (1) | PT605228E (enExample) |
| RU (1) | RU2129553C1 (enExample) |
| TW (1) | TW245716B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113112A (en) * | 1994-03-28 | 2000-06-01 | Nissan Chemical Ind Ltd | Pyridine substituted thiazolidinediones and pharmaceutical compositions comprising them |
| WO1996005186A1 (en) * | 1994-08-10 | 1996-02-22 | Takeda Chemical Industries, Ltd. | Thiazolidinedione derivatives, their production and use |
| US5641796A (en) * | 1994-11-01 | 1997-06-24 | Eli Lilly And Company | Oral hypoglycemic agents |
| US5925656A (en) * | 1995-04-10 | 1999-07-20 | Dr. Reddy's Research Foundation | Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| ZA973848B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
| ZA973850B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
| US5919782A (en) * | 1996-05-06 | 1999-07-06 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| USRE39266E1 (en) | 1996-07-01 | 2006-09-05 | Dr. Reddy's Laboratories, Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| AU744518B2 (en) | 1996-07-01 | 2002-02-28 | Dr. Reddy's Laboratories Limited | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US6372750B2 (en) | 1996-07-01 | 2002-04-16 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
| US6114526A (en) * | 1996-07-01 | 2000-09-05 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US5885997A (en) * | 1996-07-01 | 1999-03-23 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| WO1997041097A2 (en) * | 1996-12-31 | 1997-11-06 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| JP2000514041A (ja) * | 1996-07-26 | 2000-10-24 | ドクター・レディーズ・リサーチ・ファウンデーション | 抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物 |
| TW577875B (en) * | 1997-01-31 | 2004-03-01 | Shionogi & Co | Pyrrolidine derivatives with inhibitory activity for phospholipase A2 |
| EP0981526B1 (en) * | 1997-05-02 | 2004-02-25 | Dr. Reddy's Laboratories Ltd. | Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| GB9726568D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| UA75569C2 (en) * | 1998-12-01 | 2006-05-15 | Reddys Lab Ltd Dr | Pharmaceutical composition of thiadiazolidinedione and method for its manufacture |
| JP4316787B2 (ja) * | 2000-01-11 | 2009-08-19 | 壽製薬株式会社 | エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、 |
| US20030212138A1 (en) * | 2002-01-14 | 2003-11-13 | Pharmacia Corporation | Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| US20030220374A1 (en) * | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
| US20050107387A1 (en) * | 2003-05-13 | 2005-05-19 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| WO2011079274A1 (en) * | 2009-12-23 | 2011-06-30 | Jasco Pharmaceuticals, LLC | Aminopyrimidine kinase inhibitors |
| CN101824032B (zh) * | 2010-04-23 | 2015-09-09 | 浙江华海药业股份有限公司 | 一种制备盐酸吡格列酮的工艺改进方法 |
| BR112014010563B1 (pt) | 2011-11-04 | 2021-01-12 | Jasco Pharmaceuticals, LLC | compostos inibidores da aminopirimidina quinase |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5364586A (en) * | 1976-11-19 | 1978-06-09 | Takeda Chemical Industries Ltd | Emission driving device for blood detector |
| JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| JPS5564586A (en) * | 1978-11-09 | 1980-05-15 | Takeda Chem Ind Ltd | Thiazolidine derivative |
| US4296237A (en) * | 1979-09-11 | 1981-10-20 | Merck & Co., Inc. | 4-(Pyridyl, piperazinyl and thiazolyl substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones |
| NZ202797A (en) * | 1981-12-28 | 1985-08-30 | Lilly Co Eli | Pyrimidine derivatives and pharmaceutical compositions |
| CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| WO1986006069A1 (fr) * | 1985-04-09 | 1986-10-23 | Takeda Chemical Industries, Ltd. | Derives de thiazolidinedione, leur procede de preparation et composition medicinale les contenant |
| JPH06779B2 (ja) * | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
| US5130379A (en) * | 1988-03-08 | 1992-07-14 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| WO1989008651A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
| US5143930A (en) * | 1990-02-07 | 1992-09-01 | Sankyo Company, Limited | Thiazolidine derivatives with anti-diabetic activity, their preparation and their use |
| RU2066322C1 (ru) * | 1991-06-28 | 1996-09-10 | Киевский Государственный Университет Им.Т.Г.Шевченко | 3-(4-метил-2-тиазолил)-6-пропил-7-(1-метил-1-этоксикарбонил)метоксихромон, обладающий гипогликемическим, гиполипидемическим действием и аналептическим действием |
-
1993
- 1993-12-15 TW TW082110623A patent/TW245716B/zh active
- 1993-12-20 MY MYPI93002764A patent/MY110142A/en unknown
- 1993-12-21 AU AU52613/93A patent/AU666414B2/en not_active Ceased
- 1993-12-23 CZ CZ19932876A patent/CZ288363B6/cs not_active IP Right Cessation
- 1993-12-23 DK DK93310529T patent/DK0605228T3/da active
- 1993-12-23 DE DE69327944T patent/DE69327944T2/de not_active Expired - Fee Related
- 1993-12-23 AT AT93310529T patent/ATE190052T1/de not_active IP Right Cessation
- 1993-12-23 CA CA002112283A patent/CA2112283A1/en not_active Abandoned
- 1993-12-23 ES ES93310529T patent/ES2142852T3/es not_active Expired - Lifetime
- 1993-12-23 EP EP93310529A patent/EP0605228B1/en not_active Expired - Lifetime
- 1993-12-23 PT PT93310529T patent/PT605228E/pt unknown
- 1993-12-24 JP JP32839193A patent/JP3741452B2/ja not_active Expired - Fee Related
- 1993-12-27 RU RU93056838A patent/RU2129553C1/ru active
- 1993-12-27 KR KR1019930029987A patent/KR100292363B1/ko not_active Expired - Fee Related
- 1993-12-27 FI FI935887A patent/FI935887L/fi unknown
- 1993-12-27 HU HU9303757A patent/HUT69383A/hu unknown
- 1993-12-27 NO NO934833A patent/NO300735B1/no not_active IP Right Cessation
- 1993-12-28 CN CN93121754A patent/CN1056372C/zh not_active Expired - Fee Related
-
1994
- 1994-01-03 MX MX9400190A patent/MX9400190A/es not_active IP Right Cessation
-
1995
- 1995-01-23 US US08/376,529 patent/US5489602A/en not_active Expired - Lifetime
-
2000
- 2000-05-24 GR GR20000401184T patent/GR3033487T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO934833D0 (no) | 1993-12-27 |
| US5489602A (en) | 1996-02-06 |
| KR100292363B1 (ko) | 2001-09-17 |
| DK0605228T3 (da) | 2000-06-05 |
| RU2129553C1 (ru) | 1999-04-27 |
| MY110142A (en) | 1998-02-28 |
| AU5261393A (en) | 1994-07-07 |
| DE69327944D1 (de) | 2000-04-06 |
| CN1094726A (zh) | 1994-11-09 |
| GR3033487T3 (en) | 2000-09-29 |
| JPH0782269A (ja) | 1995-03-28 |
| CZ287693A3 (en) | 1994-12-15 |
| FI935887A7 (fi) | 1994-06-29 |
| HUT69383A (en) | 1995-09-28 |
| AU666414B2 (en) | 1996-02-08 |
| FI935887A0 (fi) | 1993-12-27 |
| KR940014392A (ko) | 1994-07-18 |
| CZ288363B6 (en) | 2001-06-13 |
| JP3741452B2 (ja) | 2006-02-01 |
| EP0605228B1 (en) | 2000-03-01 |
| DE69327944T2 (de) | 2000-10-19 |
| ES2142852T3 (es) | 2000-05-01 |
| EP0605228A1 (en) | 1994-07-06 |
| MX9400190A (es) | 1994-07-29 |
| CA2112283A1 (en) | 1994-06-29 |
| TW245716B (enExample) | 1995-04-21 |
| CN1056372C (zh) | 2000-09-13 |
| NO934833L (no) | 1994-06-29 |
| HU9303757D0 (en) | 1994-04-28 |
| PT605228E (pt) | 2000-06-30 |
| FI935887L (fi) | 1994-06-29 |
| ATE190052T1 (de) | 2000-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0605228B1 (en) | Thiazolidinedione derivatives, their production and use | |
| CA1277323C (en) | Thiazolidinedione derivatives, their production and use | |
| US6030990A (en) | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same | |
| DE3689924T4 (de) | Durch eine heterocyclische Gruppe substituierte Phenoxyalkylisoxazole und ihre Verwendung als antivirale Mittel. | |
| US5059614A (en) | Novel isoxazole and isoxazoline compounds with anticonvulsant activity process for their preparation and therapeutic composition containing them | |
| Cao et al. | Syntheses and insecticidal activity of new 2-(5-(trifluoromethyl) pyridyloxymethyl)-1, 3, 4-oxadiazoles | |
| IE912772A1 (en) | Novel compounds | |
| SK109993A3 (en) | Thiazolidinedione derivatives producing and use thereof | |
| NO329617B1 (no) | Tiazolderivater med CB1-antagonistisk, agonistisk eller partiell agonistisk aktivitet | |
| NZ328900A (en) | Substituted phenyl or pyridyl substituted phenyl, benzo[b]furan or indolyl derivatives and medicaments | |
| WO1994029285A1 (en) | Heterocyclic derivatives and their use in pharmaceuticals | |
| DE69432542T2 (de) | Tetraderivate, ihre Herstellung und Verwendung | |
| ITMI20010042A1 (it) | Composti di eteri e di ammidi e loro preparazione come antidiabetici | |
| US5258397A (en) | 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions | |
| US4861791A (en) | Dihydro-oxazolyl substituted-phenyl-aliphatic lower alkyl and their use as antiviral agents | |
| WO1995003288A1 (en) | Heteroaromatic derivatives and their use in therapeutics | |
| US5239080A (en) | Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents | |
| US6147101A (en) | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same | |
| DK167873B1 (da) | Substituerede pyridin-2,4-dicarboxylsyrederivater, samt laegemidler indeholdende disse derivater | |
| EP4735423A1 (en) | Kv7 modulators | |
| US5371098A (en) | Use of oxazole compounds to treat osteoporosis | |
| WO1994029302A1 (en) | Heterocyclic derivatives and their use in pharmaceuticals | |
| JP3466273B2 (ja) | テトラゾール誘導体、その製造法およびそれを含んでなる医薬 | |
| WO2006042955A1 (fr) | Derives de pyridine, leur preparation, leur application en therapeutique | |
| US5589492A (en) | Heterocyclic compounds and their use in the treatment of Type-II diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JUNE 2003 |